Published in Blood Weekly, August 3rd, 2006
Study 1: Early diagnostic implantable loop recorder (ILR) documentation and therapy delayed until documentation of syncope, allows safe, specific, and effective therapy in patients with neurally mediated syncope (NMS).
According to recent research from Italy, "This prospective multicentre observational study assessed the efficacy of specific therapy based on ILR diagnostic observations in patients with recurrent suspected NMS. Patients with three or more clinically severe syncopal episodes in the last 2 years without significant electrocardiographic and cardiac...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.